Article
Genaissance pharmaceuticals, inc.
Pharmacogenomics - 1 Mar 2002
Oestreicher Paul
Abstract excerpt
Genaissance Pharmaceuticals, Inc. (Nasdaq: GNSC) is the world leader in the discovery and use of gene variation for the development of personalized medicines. In addition, the company has established partnerships with some of the world's top biopharmaceutical companies. The company has initiated the development of its own pipeline of products -- HAP Clozapine for schizophrenia and HAP Statin for cholesterol...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
